mitaplatin

Known as: c,t,c-(Pt(NH3)2(O2CHCl2)2Cl2) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2012
01220092012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Nanoparticle (NP) therapeutics have the potential to significantly alter the in vivo biological properties of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Encapsulation of the platinum(IV) prodrug mitaplatin in block copolymer nanoparticles increases drug circulation time in the… (More)
  • table 1
Is this relevant?
2012
2012
Tumor resistance to chemotherapy is the major obstacle to employ cisplatin, one of the broadly used chemotherapeutic drugs, for… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The unique glycolytic metabolism of most solid tumors, known as the Warburg effect, is associated with resistance to apoptosis… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
The unique glycolytic metabolism of most solid tumors, known as the Warburg effect, is associated with resistance to apoptosis… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?